Atlas Trials

Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris

Clinical trial NCT00834210 · COMPLETED

Trial details

NCT number
NCT00834210
Sponsor
Allergan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Acne Vulgaris
Start date
2008-12-01
Primary completion
2009-09-01
Enrollment
171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.